The CD20 monoclonal antibodies market is growing significantly due to increasing incidence of autoimmune diseases and hematological cancers. These therapies are widely used in treating lymphoma, leukemia, and multiple sclerosis. Advancements in biosimilars and next-generation antibodies are improving treatment affordability and efficacy. https://www.databridgemarketresearch.com/reports/global-cd20-monoclonal-antibodies-market